Related Experiment Video
Updated: Mar 18, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Chemotherapy for metastatic castration-sensitive prostate cancer
Sunil Parimi1, Kim N Chi1,2
1British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Docetaxel offers a new treatment for metastatic castration-sensitive prostate cancer, improving survival. Ongoing research focuses on optimal patient selection for this chemotherapy in prostate cancer care.
Area of Science:
- Oncology
- Urology
Background:
- Metastatic castration-sensitive prostate cancer (mCSPC) treatment options have historically seen limited advancement.
- Chemo-hormonal therapy attempts for mCSPC previously yielded unsuccessful outcomes.
- Docetaxel demonstrated survival benefits in metastatic castration-resistant prostate cancer (mCRPC), prompting earlier disease course investigation.
Purpose of the Study:
- To evaluate the role and benefits of docetaxel in metastatic castration-sensitive prostate cancer.
- To address the evolving treatment landscape for advanced prostate cancer.
Main Methods:
- Analysis of three randomized phase III trials investigating docetaxel in mCSPC.
- Review of clinical data and survival outcomes.
Main Results:
- Docetaxel incorporation has established it as a viable treatment option for mCSPC.
- Phase III trials have confirmed survival benefits in this patient population.
Conclusions:
- Docetaxel represents a significant addition to mCSPC treatment strategies.
- Further research is needed to define optimal patient selection criteria for docetaxel therapy in mCSPC.
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Treatment Resistent Cancers